Machine learning has moved past its initial experimental phase. In earlier years, development often focused on creating the largest possible models to see what capabilities might appear. Today, the ...

Dr. Matthew Lewis discusses why data quality is fundamental to metabolomics research, how AI‑ready workflows and upgradeable ...

Nearly 80 percent of organizations now use AI in at least one core business process, according to McKinsey, yet widespread adoption has surfaced a persistent problem: a deep shortage of professionals ...

Stanford's 2026 AI Index: frontier models fail one in three attempts, lab transparency is declining, and benchmarks are ...

None ...

Unveiling a New Era: From Sustainable Footwear to Cutting-Edge AI In a move that has sent ripples across both the ...

Debuting in Asus’ exciting 16-inch Zenbook A16, Qualcomm's 2026 flagship processor looks like a benchmark bombshell ready to ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...